OVARIAN CANCER

P53 gene can affect ovarian cancer prognosis For a long time, ovarian cancer is malignant gynecologic tumors in the highest degree. In the United States, the mortality rate since 1979 a...

British scientists find anti-female ovarian cancer gene British "Nature Genetics" recently published text, British scientists have found a gene named OPCML. 90% of women suffering from...

Abstract: a group P53 mutations in the genes in patients with advanced ovarian cancer by more cycles of P53 gene therapy and chemotherapy, reducing disease, the survival rate has improved. (The Fourth Annual Gene Therapy & Molecular Biology Conference, Rhodes, Greece)

American University of Iowa Dr. Richard Buller reported they received early treatment to strengthen the 36 patients with advanced ovarian cancer to the adenovirus vector into the peritoneal tumor suppressor gene p53 function of the combination of chemotherapy I / II clinical trials of the preliminary results. The results show that several gene therapy / chemotherapy combination therapy in patients with an average survival of 14.8. Nine people have survived 19.5 months, are still alive. The survival rate is higher than five separate gene therapy on the survival rate is also higher than the average with paclitaxel (Taxol) in the treatment of recurrent ovarian cancer new 15-month survival rate.

Buller said that the combination of chemotherapy treatment and gene therapy of synergies. Completed three of the patients showed that 44% of in vivo tumor marker CA125 reduced more than 50%. Buller that ovarian cancer is very suitable for gene therapy because even with advanced performance, in general, limited to the transfer of intraperitoneal.

They recently started a large-scale random P53 gene therapy Phase III clinical, patients will receive carboplatin (Carboplatin) and paclitaxel (Taxol) or carboplatin, paclitaxel and P53 gene therapy.

Aspirin can cure skin cancer According to the latest issue of "Nature" magazine reported, the scientists found that people commonly used analgesic drugs for the treatme...

Beware of genetic factors of ovarian cancer The possible risk of ovarian cancer risk factors, including age, not infertility, diet, ovulation drug therapy. But if family history of br...

Epithelial ovarian cancer proven mechanism Henan Medical University, a professor of obstetrics and gynecology buildings Qiao Yu, graduate students and others Rui - Xia Guo recent stud...

Ovarian cancer is laying? Currently, the incidence rates of ovarian cancer accounts for gynecologic malignancy in 23% ~ 27% as the world's five largest high cance...

Group of protein in ovarian cancer diagnosis of Ovarian cancer is the female reproductive system cancer one of the three, as misprision of clinical symptoms, the lack of an effective meth...

Recurrent ovarian cancer may reoperation Health, will be right recurrent ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Fourth Militar...

Ovarian cancer can also early detection

New research provides an assessment of the risk of ovarian cancer women practical method

Tags: age, cancer, carboplatin, cause, chemotherapy, clinical, early, eat, gene, group, intraperitoneal, mutation, ovarian, p53, paclitaxel, patients, rate, reduce, survival, taxol, therapy, treatment, tumor